Skip to content

Clinical trials

Withdrawn Carcinoma, Non-Small-Cell Lung trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Withdrawn Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20151
20181
20191
20201
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut Bergonié2
AstraZeneca1
Bristol-Myers Squibb1
Centre Hospitalier Universitaire de Nice1
ETOP IBCSG Partners Foundation1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
University Hospital, Grenoble1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms2
Biliary Tract Neoplasms1
Camurati-Engelmann Syndrome1
Carcinoma1
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1
Colorectal Neoplasms1
Sarcoma1
Tertiary Lymphoid Structures1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.